How to Buy Ekso Bionics Holdings Stock
Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally.
Ekso Bionics Holdings stock last closed at $1.32, up 9.09% from the previous day, and has decreased 22.35% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0.08 percentage points. Ekso Bionics Holdings stock is currently +112.9% from its 52-week low of $0.62, and -57.8% from its 52-week high of $3.13.
As of Apr 19, 2024, there are 17.9M shares of EKSO outstanding. The market value of EKSO is $23.63M. In the past 24 hours, 53,526 EKSO shares were traded.
How to Buy Ekso Bionics Holdings Stock
Not sure how to invest in Ekso Bionics Holdings stock? Here's how.
- Decide where to buy Ekso Bionics Holdings stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you determine where to buy Ekso Bionics Holdings stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit money your investment account: Select your payment method and add your information.
- Analyze Ekso Bionics Holdings stock: The Ekso Bionics Holdings ticker symbol is EKSO. Is Ekso Bionics Holdings stock a good investment? Should you buy shares of EKSO? How do EKSO's underlying business fundamentals look? Do top analysts think Ekso Bionics Holdings is a good buy? Why has EKSO's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if EKSO is a good stock to buy).
- Execute your EKSO buy order: Decide if you will purchase EKSO shares at the current market price or use a limit order to purchase EKSO shares at a specific price.
- Keep an eye on your investment in EKSO: Create a watchlist to monitor your position in Ekso Bionics Holdings stock.
Step 1: Decide where to buy Ekso Bionics Holdings stock
You will need a brokerage account to access the NASDAQ market and buy EKSO shares.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Real Estate, New York to London — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal information so you can invest in EKSO today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open your new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have created your account on our top ranked stock trading app, your next step is to transfer the money for your investment:
Check out the video below for more details depositing money into your investment account.
Step 4: Analyze Ekso Bionics Holdings stock
After you have chosen the best place to buy Ekso Bionics Holdings stock, it's very important to analyze their stock prior to investing, so you actually wrap your head around the risk as well as the upside.
Ekso Bionics Holdings Metrics
Fundamentals of EKSO
WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on EKSO's stock page.
Is EKSO stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge EKSO's true value.
Using relative valuations metrics:
- EKSO may be undervalued based on its P/B ratio of 1.87x, relative to Medical Instruments & Supplies industry P/B ratio of 3.46x
You can access more valuation research on EKSO's stock here.
EKSO Financial Health
Signs that EKSO is financially healthy:
- Total EKSO debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the EKSO balance sheet.
- There are more short-term assets than short-term liabilities on the EKSO balance sheet.
Signs that EKSO is not financially healthy:
- EKSO has $8.64M in cash and short term investments. This is not enough to cover its annual cash burn of $12.21M.
- EKSO has a relatively high debt to equity ratio of 1.29.
- EKSO profit margin has gone up by 0.34 percentage points in the past year, but the company is still unprofitable.
- EKSO has cash burn of 12211000. It does not have enough cash and short-term investments to cover this.
Is EKSO stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 1 sell side analysts who give ratings on EKSO, the consensus analyst rating on EKSO is a Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Ekso Bionics Holdings stock forecast page.
EKSO Technical Indicators
EKSO Growth Numbers
Last year, EKSO revenue was $18.28M. During the last five year, EKSO's revenue has increased by 10.03% per year. This was faster than the Medical Instruments & Supplies industry average of 9.4%.
Dig into EKSO's earnings and revenue performance here.
Are EKSO executives and large shareholders buying or selling the stock?
In the last year, insiders at EKSO have sold more shares than they have bought.
Corinna Lathan, Director of EKSO, was the latest EKSO insider to buy. They bought $5,003.71 worth of EKSO stock on Nov 2, 2023.
Learn more about who owns EKSO stock here.
Does EKSO stock generate passive income?
No, Ekso Bionics Holdings doesn't provide an income stream by paying out dividends.
What others are saying about EKSO
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your EKSO buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.
Click the Open Trade button and your broker will execute the order.
If you need more info about investing in stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your investment in EKSO
Now that you own some EKSO shares, you'll want to stay up-to-date on your new company.
Add EKSO to a watchlist to see the latest developments about your EKSO stock.
EKSO Feed
How to Buy Stock in Ekso Bionics Holdings
To reiterate, here are the 6 steps to buy stock in Ekso Bionics Holdings:
- Decide where to buy Ekso Bionics Holdings stock
- Open a brokerage account
- Deposit money your investment account
- Analyze Ekso Bionics Holdings stock
- Execute your EKSO buy order
- Keep an eye on your investment in EKSO
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep track of your new investment in Ekso Bionics Holdings, add EKSO to your watchlist by clicking the button below.
More Content You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.